243 related articles for article (PubMed ID: 20562782)
21. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
Montgomery SA; Huusom AK; Bothmer J
Neuropsychobiology; 2004; 50(1):57-64. PubMed ID: 15179022
[TBL] [Abstract][Full Text] [Related]
22. Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders.
Leon AC; Fiedorowicz JG; Solomon DA; Li C; Coryell WH; Endicott J; Fawcett J; Keller MB
J Clin Psychiatry; 2014 Jul; 75(7):720-7. PubMed ID: 25093469
[TBL] [Abstract][Full Text] [Related]
23. Rapid onset of action of venlafaxine.
Montgomery SA
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerance profile of venlafaxine.
Danjou P; Hackett D
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():15-20. PubMed ID: 7622813
[TBL] [Abstract][Full Text] [Related]
25. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of venlafaxine.
Ballenger JC
J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S. PubMed ID: 8784646
[TBL] [Abstract][Full Text] [Related]
27. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
Rihmer Z; Akiskal H
J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
[TBL] [Abstract][Full Text] [Related]
28. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
Clerc GE; Ruimy P; Verdeau-Pallès J
Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
[TBL] [Abstract][Full Text] [Related]
29. Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.
Begré S; Traber M; Gerber M; von Känel R
Eur Psychiatry; 2008 Apr; 23(3):178-86. PubMed ID: 18328675
[TBL] [Abstract][Full Text] [Related]
30. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
31. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
Alevizos B; Alevizos E; Leonardou A; Zervas I
Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of venlafaxine in comparison with other antidepressants.
Lecrubier Y
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():29-35. PubMed ID: 7622815
[TBL] [Abstract][Full Text] [Related]
33. Venlafaxine and ecchymosis.
Kohn S; Labbate LA
Can J Psychiatry; 1997 Feb; 42(1):91. PubMed ID: 9040933
[No Abstract] [Full Text] [Related]
34. Antidepressant-induced or clinician-induced suicidality in depression?
Benazzi F
Am J Psychiatry; 2006 Sep; 163(9):1644; author reply 1644-5. PubMed ID: 16946197
[No Abstract] [Full Text] [Related]
35. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
Dursun SM; Devarajan S
Psychopharmacology (Berl); 2001 Feb; 153(4):497-8. PubMed ID: 11243498
[No Abstract] [Full Text] [Related]
36. Venlafaxine: a 2003 update.
Gutierrez MA; Stimmel GL; Aiso JY
Clin Ther; 2003 Aug; 25(8):2138-54. PubMed ID: 14512125
[TBL] [Abstract][Full Text] [Related]
37. Suicidal ideas with paroxetine or venlafaxine.
Prescrire Int; 2004 Feb; 13(69):21. PubMed ID: 15055220
[No Abstract] [Full Text] [Related]
38. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant monotherapy for bipolar type II major depression.
Amsterdam JD; Brunswick DJ
Bipolar Disord; 2003 Dec; 5(6):388-95. PubMed ID: 14636362
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
